An important message regarding the current COVID-19 pandemic. Click here to read more.

Pheochromocytoma

Multiple

Overview

One patient with seemingly unrelated signs and symptoms. Can you treat him correctly?


  1. Anesthesia techniques for pheochromocytoma resection
  2. CT imaging of a suspected pheochromocytoma
  3. Diagnosis of pheochromocytoma
  4. Imaging a suspected pheochromocytoma
  5. Magnetic resonance imaging of a suspected pheochromocytoma
  6. Multiple endocrine neoplasia type 2 (MEN2)
  7. Neurofibromatosis type 1
  8. Phenoxybenzamine: use in pheochromocytoma and side effects
  9. Pheochromocytoma: definition and clinical manifestations
  10. Pheochromocytoma: why pre-operative preparation is essential
  11. Post-operative follow-up of the patient with pheochromocytoma
  12. Postoperative evaluation and management of the patient with pheochromocytoma
  13. Pre-operative preparation for surgical resection of a pheochromocytoma
  14. Preoperative medical management for pheochromocytoma
  15. Selective α-1 antagonists in pheochromocytoma
  16. Surgical approach for pheochromocytoma resection
  17. Von Hippel-Lindau syndrome
  18. When to biopsy an adrenal mass
  1. BAJWA SS, BAJWA SK. Implications and considerations during pheochromocytoma resection: A challenge to the anesthesiologist Indian J Endocrinol Metab [online] 2011 Oct, 15(Suppl4):S337-S344 [viewed 13 July 2016] Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3230104
  2. BESSELL-BROWNE R, O'MALLEY ME. CT of pheochromocytoma and paraganglioma: risk of adverse events with i.v. administration of nonionic contrast material. AJR Am J Roentgenol [online] 2007 Apr, 188(4):970-4 [viewed 13 July 2016] Available from: http://www.ncbi.nlm.nih.gov/pubmed/17377032
  3. BLAKE MA, KALRA MK, MAHER MM, SAHANI DV, SWEENEY AT, MUELLER PR, HAHN PF, BOLAND GW. Pheochromocytoma: an imaging chameleon. Radiographics [online] 2004 Oct:S87-99 [viewed 14 July 2016] Available from: http://www.ncbi.nlm.nih.gov/pubmed/15486252
  4. CHEN H, SIPPEL RS, PACAK K. The NANETS Consensus Guideline for the Diagnosis and Management of Neuroendocrine Tumors: Pheochromocytoma, Paraganglioma & Medullary Thyroid Cancer Pancreas [online] 2010 Aug, 39(6):775-783 [viewed 10 July 2016] Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3419007
  5. DäRR R, LENDERS JW, HOFBAUER LC, NAUMANN B, BORNSTEIN SR, EISENHOFER G. Pheochromocytoma - update on disease management Ther Adv Endocrinol Metab [online] 2012 Feb, 3(1):11-26 [viewed 10 July 2016] Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3474647
  6. FRIEDRICH CA. Von Hippel-Lindau syndrome. A pleomorphic condition. Cancer [online] 1999 Dec 1, 86(11 Suppl):2478-82 [viewed 14 July 2016] Available from: http://www.ncbi.nlm.nih.gov/pubmed/10630173
  7. GARG MK, KHARB S, BRAR KS, GUNDGURTHI A, MITTAL R. Medical management of pheochromocytoma: Role of the endocrinologist Indian J Endocrinol Metab [online] 2011 Oct, 15(Suppl4):S329-S336 [viewed 13 July 2016] Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3230088
  8. GUT P, KOMAROWSKA H, CZARNYWOJTEK A, WALIGóRSKA-STACHURA J, BąCZYK M, ZIEMNICKA K, FISCHBACH J, WROTKOWSKA E, RUCHAłA M. Familial syndromes associated with neuroendocrine tumours Contemp Oncol (Pozn) [online] 2015 Jul 8, 19(3):176-183 [viewed 14 July 2016] Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4631294
  9. GUéRIN M, GUILLEMOT J, THOUëNNON E, PIERRE A, EL-YAMANI FZ, MONTERO-HADJADJE M, DUBESSY C, MAGOUL R, LIHRMANN I, ANOUAR Y, YON L. Granins and their derived peptides in normal and tumoral chromaffin tissue: Implications for the diagnosis and prognosis of pheochromocytoma. Regul Pept [online] 2010 Nov 30, 165(1):21-9 [viewed 10 July 2016] Available from: http://www.ncbi.nlm.nih.gov/pubmed/20600356
  10. JALIL ND, PATTOU FN, COMBEMALE F, CHAPUIS Y, HENRY JF, PEIX JL, PROYE CA. Effectiveness and limits of preoperative imaging studies for the localisation of pheochromocytomas and paragangliomas: a review of 282 cases. French Association of Surgery (AFC), and The French Association of Endocrine Surgeons (AFCE). Eur J Surg [online] 1998 Jan, 164(1):23-8 [viewed 13 July 2016] Available from: http://www.ncbi.nlm.nih.gov/pubmed/9537705
  11. LENDERS JW, DUH QY, EISENHOFER G, GIMENEZ-ROQUEPLO AP, GREBE SK, MURAD MH, NARUSE M, PACAK K, YOUNG WF JR, ENDOCRINE SOCIETY. Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab [online] 2014 Jun, 99(6):1915-42 [viewed 14 July 2016] Available from: http://www.ncbi.nlm.nih.gov/pubmed/24893135
  12. MAHER ER, NEUMANN HP, RICHARD S. von Hippel-Lindau disease: A clinical and scientific review Eur J Hum Genet [online] 2011 Mar 9, 19(6):617-623 [viewed 14 July 2016] Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3110036
  13. MAUREA S, CUOCOLO A, REYNOLDS JC, NEUMANN RD, SALVATORE M. Diagnostic imaging in patients with paragangliomas. Computed tomography, magnetic resonance and MIBG scintigraphy comparison. Q J Nucl Med [online] 1996 Dec, 40(4):365-71 [viewed 13 July 2016] Available from: http://www.ncbi.nlm.nih.gov/pubmed/9050342
  14. MOLINE J, ENG C. Multiple endocrine neoplasia type 2: an overview. Genet Med [online] 2011 Sep, 13(9):755-64 [viewed 14 July 2016] Available from: http://www.ncbi.nlm.nih.gov/pubmed/21552134
  15. PRYS-ROBERTS C, FARNDON JR. Efficacy and safety of doxazosin for perioperative management of patients with pheochromocytoma. World J Surg [online] 2002 Aug, 26(8):1037-42 [viewed 14 July 2016] Available from: http://www.ncbi.nlm.nih.gov/pubmed/12192533
  16. RAUE F, ZINK A. Clinical features of multiple endocrine neoplasia type 1 and type 2. Horm Res [online] 1992:31-5 [viewed 14 July 2016] Available from: http://www.ncbi.nlm.nih.gov/pubmed/1363414
  17. SAWKA AM, JAESCHKE R, SINGH RJ, YOUNG WF JR. A comparison of biochemical tests for pheochromocytoma: measurement of fractionated plasma metanephrines compared with the combination of 24-hour urinary metanephrines and catecholamines. J Clin Endocrinol Metab [online] 2003 Feb, 88(2):553-8 [viewed 10 July 2016] Available from: http://www.ncbi.nlm.nih.gov/pubmed/12574179
  18. SCHMEDTJE JF JR, SAX S, POOL JL, GOLDFARB RA, NELSON EB. Localization of ectopic pheochromocytomas by magnetic resonance imaging. Am J Med [online] 1987 Oct, 83(4):770-2 [viewed 13 July 2016] Available from: http://www.ncbi.nlm.nih.gov/pubmed/3674064
  19. VANDERVEEN KA, THOMPSON SM, CALLSTROM MR, YOUNG WF JR, GRANT CS, FARLEY DR, RICHARDS ML, THOMPSON GB. Biopsy of pheochromocytomas and paragangliomas: potential for disaster. Surgery [online] 2009 Dec, 146(6):1158-66 [viewed 14 July 2016] Available from: http://www.ncbi.nlm.nih.gov/pubmed/19958944
  20. WISEMAN GA, PACAK K, O'DORISIO MS, NEUMANN DR, WAXMAN AD, MANKOFF DA, HEIBA SI, SERAFINI AN, TUMEH SS, KHUTORYANSKY N, JACOBSON AF. Usefulness of 123I-MIBG scintigraphy in the evaluation of patients with known or suspected primary or metastatic pheochromocytoma or paraganglioma: results from a prospective multicenter trial. J Nucl Med [online] 2009 Sep, 50(9):1448-54 [viewed 14 July 2016] Available from: http://www.ncbi.nlm.nih.gov/pubmed/19690028
  21. ZUBER SM, KANTOROVICH V, PACAK K. Hypertension in Pheochromocytoma: Characteristics and Treatment Endocrinol Metab Clin North Am [online] 2011 Jun, 40(2):295-311 [viewed 10 July 2016] Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3094542